It’ll be marketed as Spikevax.
, a designation that allows the FDA to sign off on products quickly during an emergency. Now that it’s fully licensed, Moderna is able to advertise its shot directly to patients. It’ll be marketed under the brand name Spikevax.
The full approval is based on clinical trial data from nearly 30,000 people, which showed the vaccine was safe and effective protection against COVID-19. There’s also a year of real-world data for this vaccine, which has been administered to tens of millions of people in the US. Along with the other COVID-19 shots available, it’s saved millions of lives through the last year of the COVID-19 pandemic.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Moderna's COVID-19 vaccine gets full FDA approvalModerna's COVID-19 vaccine called “Spikevax” has been given full approval from the U.S. Food and Drug Administration.
Weiterlesen »
Moderna COVID-19 vaccine gets full FDA approvalThe Moderna Covid-19 vaccine received full approval from the U.S. Food and Drug administration Monday, 11 months after the shot was given an emergency use authorization.
Weiterlesen »
Moderna's COVID-19 vaccine granted full FDA approval, company saysModerna says the Food and Drug Administration has issued full approval for its COVID-19 vaccine for use in people aged 18 and older.
Weiterlesen »
FDA Gives Moderna Full Approval for Its COVID-19 VaccineModerna says U.S. health regulators have given full approval to its COVID-19 vaccine after reviewing additional data on its safety and effectiveness
Weiterlesen »
Could there be a universal vaccine for any type of coronavirus, not just COVID-19?A pan-coronavirus vaccine will be designed using features of the virus's genetic code that are shared universally across all different versions of the virus.
Weiterlesen »